Watch Ticker

Cognition Therapeutics, Inc. Common Stock

Go to Cognition Therapeutics, Inc. Common Stock Website

$0.72

0.01 (1.23%)

Live

Previous Close

$0.716

Day Range

$0 - $0

Previous Day Range

$0.7101 - $0.74

Market Cap

$44.3 million USD

Day Vol.

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Cognition Therapeutics, Inc. - Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update

Cognition Therapeutics reported positive results from its Phase 2 studies of zervimesine (CT1812) in dementia with Lewy bodies (DLB) and Alzheimer's disease. The company plans to advance zervimesine into late-stage trials for these indications.

Related tickers: CGTX.

Read Full Article

N/A - Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD

Cognition Therapeutics presented positive results from a pre-specified analysis of its Phase 2 SHINE study, showing that its drug candidate CT1812 dramatically slowed cognitive decline in Alzheimer's disease patients with lower levels of the biomarker p-tau217.

Related tickers: CGTX.

Read Full Article

Trending Tickers

Please sign in to view